The Economic Burden of Breast Cancer in Korea from 2007-2010
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Koreabetween 2007 and 2010. Materials and MethodsThis study used a prevalence-based approach to estimate the cost of breast cancer. Breastcancer patients were defined as those who were hospitalized or have visited an outpatientclinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer weresubdivided into two costs: direct and indirect. ResultsFrom 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7%from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical carecosts for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, thetotal indirect costs were US $339.09 million in 2007 and increased by 37.3% to US$465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for eachyear ranging from 0%-5%, the costs increased 1.1-1.2 times. ConclusionDue to the growing incidence of breast cancer, the annual prevalence and related costs areincreasing. We must strive to reduce the socioeconomic burden of breast cancer throughpreventive measures and early screening.
Abstract
Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Koreabetween 2007 and 2010. Materials and MethodsThis study used a prevalence-based approach to estimate the cost of breast cancer. Breastcancer patients were defined as those who were hospitalized or have visited an outpatientclinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer weresubdivided into two costs: direct and indirect. ResultsFrom 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7%from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical carecosts for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, thetotal indirect costs were US $339.09 million in 2007 and increased by 37.3% to US$465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for eachyear ranging from 0%-5%, the costs increased 1.1-1.2 times. ConclusionDue to the growing incidence of breast cancer, the annual prevalence and related costs areincreasing. We must strive to reduce the socioeconomic burden of breast cancer throughpreventive measures and early screening.
참고문헌 (24)
- Economist Intelligence Unit, "Breakaway: the global burden of cancer: challenges and opportunities" (2009), Economist Intelligence Unit Limited
- 2009 Annual report of cancer statistics in Korea, "Ministry of Health and Welfare", Ministry of Health and Welfare, ~ (2011)
- GLOBOCAN 2008: cancer incidence and mortality worldwide, "World Health Organization", World Health Organization, ~ (2010)
- Matsuda T, "Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan : a chronological and international comparative study", Jpn J Clin Oncol, 41, pp.40~51 (2011)
- The global economic cost of cancer, "American Cancer Society", American Cancer Society, ~ (2010)
- Health Insurance Review and Assessment Service, "National health insurance statistical yearbook 2011" (2012), National Health Insurance Corporation, Health Insurance Review and Assessment Service
- Meneses K, "Does economic burden influence quality of life in breast cancer survivors?", Gynecol Oncol, 124, pp.437~443 (2012)
- Murray CJ, "Global mortality, disability, and the contribution of risk factors : Global Burden of Disease Study", Lancet, 349, pp.1436~1442 (1997)
- Estimating the direct medical cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with eight type of cancer during 2001 to 2005, "Kim JH", Health Insurance Review and Assessment Service, ~ (2011)
- The healthy people 2000final review, "National Center for Health Statistics", Public Health Service, ~ (2001)
- Romano PS, "Folic acid fortification of grain : an economic analysis", Am J Public Health, 85, pp.667~676 (1995)
- Kim SG, "The economic burden of cancer in Korea in 2002", Eur J Cancer Care(Engl), 17, pp.136~144 (2008)
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- Jeong YH, "An estimation of economic costs of 5 major diseases", Health Welf Policy Forum, 79, pp.55~65 (2003)
- Drummond MF, "Methods for the economic evaluation of health care programmes" (1997), Oxford University Press
- Korea national statistical report on death causes 2007-2010, "Korea National Statistical Office", Korea National Statistical Office, ~ (2010)
- Mariotto AB, "Projections of the cost of cancer care in the United States : 2010-2020", J Natl Cancer Inst, 103, pp.117~128 (2011)
- Ahn SH, "Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004", Breast Cancer Res Treat, 99, pp.209~214 (2006)
- Haggar FA, "Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007", BMC Cancer, 12, pp.151~ (2012)
- Zelle SG, "Costs, effects and cost-effectiveness of breast cancer control in Ghana", Trop Med Int Health, 17, pp.1031~1043 (2012)
- Ma X, "Global burden of cancer", Yale J Biol Med, 79, pp.85~94 (2006)
- Groot MT, "Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia", Breast J, 12(Suppl 1), pp.S81~90 (2006)
- "England 2010-11" (2012)[URL]
- Evans DG, "National Health Service Breast Screening Program: a new paradigm for cancer prevention", Cancer Prev Res(Phila), 5, pp.943~951 (2012)